Allspring Global Investments
BMRN icon

Allspring Global Investments’s BioMarin Pharmaceuticals BMRN Stock Holding History

Allspring Global Investments’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.79M Buy
+65,529
New +$3.59M 0.01% 942
2025
Q4 		– Sell
-100,257
Closed -$5.5M – 1702
2025
Q3 		$5.5M Sell
100,257
-125
-0.1% -$7.15K 0.01% 848
2025
Q2 		$5.64M Sell
100,382
-1,555
-2% -$91.6K 0.01% 863
2025
Q1 		$6.93M Buy
101,937
+1,452
+1% +$97.7K 0.01% 827
2024
Q4 		$6.68M Buy
100,485
+103
+0.1% +$6.9K 0.01% 869
2024
Q3 		$7.06M Buy
100,382
+124
+0.1% +$10.4K 0.01% 855
2024
Q2 		$8.25M Sell
100,258
-21
-0% -$1.75K 0.01% 818
2024
Q1 		$8.76M Buy
100,279
+39,708
+66% +$3.55M 0.01% 800
2023
Q4 		$5.84M Buy
60,571
+59,760
+7,369% +$5.29M 0.01% 905
2023
Q3 		$71.8K Sell
811
-28,129
-97% -$2.5M ﹤0.01% 2130
2023
Q2 		$2.51M Sell
28,940
-437,747
-94% -$41.2M ﹤0.01% 1166
2023
Q1 		$45.4M Buy
466,687
+34,286
+8% +$3.55M 0.08% 361
2022
Q4 		$44.7M Buy
432,401
+427,438
+8,612% +$40.1M 0.08% 347
2022
Q3 		$420K Sell
4,963
-2,099
-30% -$187K ﹤0.01% 1624
2022
Q2 		$584K Sell
7,062
-17,898
-72% -$1.43M ﹤0.01% 1544
2022
Q1 		$1.92M Buy
24,960
+4,451
+22% +$372K ﹤0.01% 1523
2021
Q4 		$1.81M Buy
+20,509
New +$1.69M ﹤0.01% 1593

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vestal Point Capital
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Allspring Global Investments's BMRN Position: Q2 2026 in Review

Allspring Global Investments opened a new position in BioMarin Pharmaceuticals (BMRN) in Q2 2026: 65,529 shares worth $3.79M. The stake represents 0.01% of the portfolio and ranks #942 among its holdings. This is a return to the name: Allspring Global Investments previously reported a position in BMRN as recently as Q3 2025.

Allspring Global Investments first reported a position in BMRN in Q4 2021 and has held it in 17 quarters since. The position peaked at $45.4M in Q1 2023. 565 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • Allspring Global Investments held 65,529 shares of BioMarin Pharmaceuticals worth $3.79M as of Q2 2026.
  • BioMarin Pharmaceuticals was a new Allspring Global Investments position in Q2 2026.
  • BioMarin Pharmaceuticals made up 0.01% of Allspring Global Investments's portfolio in Q2 2026, its #942 holding.
  • Allspring Global Investments first reported a position in BioMarin Pharmaceuticals in Q4 2021 and has held it in 17 quarters since.
  • Allspring Global Investments's BioMarin Pharmaceuticals position peaked at $45.4M in Q1 2023.
  • 565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.